CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $779,305 | -28.6% | 86,111 | -15.1% | 0.00% | – |
Q2 2023 | $1,091,355 | -40.7% | 101,427 | -43.6% | 0.00% | – |
Q1 2023 | $1,839,558 | +3.9% | 179,820 | +7.1% | 0.00% | – |
Q4 2022 | $1,771,240 | -57.7% | 167,890 | -48.6% | 0.00% | -100.0% |
Q3 2022 | $4,189,000 | +97.7% | 326,750 | +97.7% | 0.00% | – |
Q2 2022 | $2,119,000 | +141.9% | 165,309 | +97.6% | 0.00% | – |
Q1 2022 | $876,000 | -29.4% | 83,651 | +4.0% | 0.00% | – |
Q4 2021 | $1,240,000 | -65.1% | 80,401 | -49.0% | 0.00% | -100.0% |
Q3 2021 | $3,555,000 | +1017.9% | 157,501 | +1175.0% | 0.00% | – |
Q2 2021 | $318,000 | -86.4% | 12,353 | -78.0% | 0.00% | -100.0% |
Q1 2021 | $2,336,000 | – | 56,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |